Karyopharm Therapeutics (KPTI)
(Delayed Data from NSDQ)
$0.96 USD
+0.01 (1.43%)
Updated Jul 25, 2024 04:00 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.29 | 8.62% |
Earnings Summary
For their last quarter, Karyopharm Therapeutics (KPTI) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.33 per share. This reflects a positive earnings surprise of 3.03%. Look out for KPTI's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.29 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for KPTI
Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?
KPTI: What are Zacks experts saying now?
Zacks Private Portfolio Services